We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Pfizer Over Contaminated Vials at Hospira Facility in Kansas
FDA Cites Pfizer Over Contaminated Vials at Hospira Facility in Kansas
Pfizer’s Hospira is drawing scrutiny from the FDA in a warning letter for failing to fully investigate quality defects, such as the presence of cardboard, in batches of injections and neglecting to take corrective measures.